Admedus: Superior cardiovasculartissue- repair products

Based on its proprietary ADAPT tissue-engineering technology, Admedus is developing an expanding portfolio of next-generation 3D tissue products for cardiovascular repair. The products will expand its range of durable bioscaffolds, which have achieved 10 years without calcification or degradation.

Mar 13, 2019
0
0
Page of

Admedus

Admedus is a medical technologies company delivering clinically superior solutions to help healthcare professionals to create life-changing outcomes for patients. dmedus Ltd started its life as Allied Healthcare Group Ltd when its two parent companies Allied Medical Ltd and bioMD Ltd (ASX: BOD) merged in 2011. In 2013, the Company changed its name from Allied Healthcare Group to Admedus Ltd as part of a global branding strategy, and acquired Verigen Australia Pty Ltd (now Admedus Biomanufacturing). The original merger of Allied Healthcare Group Ltd and bioMD Ltd created a unique healthcare company with assets in research & development, products in advanced clinical trials ready for commercialisation, and a successful sales, marketing and medical device distribution business. Since then, Admedus has continued to grow, expanding into new dynamic markets, investing in ground-breaking R&D and continuously refining our world-class manufacturing facility and processes.

No comments yet.